125 related articles for article (PubMed ID: 9062151)
1. Identification of high-risk groups among node-positive patients with stage IB and IIA cervical carcinoma.
Samlal RA; van der Velden J; Schilthuis MS; González González D; Ten Kate FJ; Hart AA; Lammes FB
Gynecol Oncol; 1997 Mar; 64(3):463-7. PubMed ID: 9062151
[TBL] [Abstract][Full Text] [Related]
2. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
Aoki Y; Sasaki M; Watanabe M; Sato T; Tsuneki I; Aida H; Tanaka K
Gynecol Oncol; 2000 May; 77(2):305-9. PubMed ID: 10785483
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
[TBL] [Abstract][Full Text] [Related]
4. Twelve years experience with radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer.
Suprasert P; Srisomboon J; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Kietpeerakool C; Phongnarisorn C; Sae-Teng J
J Obstet Gynaecol; 2010 Apr; 30(3):294-8. PubMed ID: 20373935
[TBL] [Abstract][Full Text] [Related]
5. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
Samlal RA; van der Velden J; Ten Kate FJ; Schilthuis MS; Hart AA; Lammes FB
Cancer; 1997 Oct; 80(7):1234-40. PubMed ID: 9317173
[TBL] [Abstract][Full Text] [Related]
6. Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer.
Hongladaromp W; Tantipalakorn C; Charoenkwan K; Srisomboon J
Asian Pac J Cancer Prev; 2014; 15(2):887-90. PubMed ID: 24568513
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in stage IB-IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy.
Kodama J; Seki N; Masahiro S; Kusumoto T; Nakamura K; Hongo A; Hiramatsu Y
J Surg Oncol; 2010 Apr; 101(5):413-7. PubMed ID: 20127891
[TBL] [Abstract][Full Text] [Related]
8. A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB-IIA.
Lee YY; Choi CH; Kim TJ; Lee JW; Kim BG; Lee JH; Bae DS
Gynecol Oncol; 2011 Mar; 120(3):439-43. PubMed ID: 21145099
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
[TBL] [Abstract][Full Text] [Related]
10. The role of radical surgery followed by adjuvant therapy for high-risk early-stage cervical carcinoma patients with pelvic lymph node metastasis.
Lin H; ChangChien CC; Huang EY; Eng HL; Huang CC
Eur J Obstet Gynecol Reprod Biol; 2000 Nov; 93(1):85-90. PubMed ID: 11000510
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma.
Piver MS; Chung WS
Obstet Gynecol; 1975 Nov; 46(5):507-10. PubMed ID: 1196552
[TBL] [Abstract][Full Text] [Related]
12. Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.
Tuipae S; Yanaranop M; Oniem N
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S117-24. PubMed ID: 22619897
[TBL] [Abstract][Full Text] [Related]
13. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in patients with with locally advanced cervical cancer treated with radical hysterectomy and adjuvant radiotherapy.
Frigerio L; Mariani A; Gandini L; Origoni M; Galli L; Rabaiotti E; Aletti G; Ferrari A
Int Surg; 1998; 83(3):265-70. PubMed ID: 9870789
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB-IIA cervical cancer.
Xie X; Song K; Cui B; Jiang J; Yang X; Kong B
Int J Clin Oncol; 2018 Jun; 23(3):522-531. PubMed ID: 29299705
[TBL] [Abstract][Full Text] [Related]
17. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma of the uterine cervix stage IB and IIA: results of postoperative irradiation in patients with microscopic infiltration in the parametrium and/or lymph node metastasis.
González González D; Ketting BW; van Bunningen B; van Dijk JD
Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):389-95. PubMed ID: 2921143
[TBL] [Abstract][Full Text] [Related]
19. Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy.
Irie T; Kigawa J; Minagawa Y; Itamochi H; Sato S; Akeshima R; Terakawa N
Eur J Surg Oncol; 2000 Aug; 26(5):464-7. PubMed ID: 11016467
[TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix.
Alvarez RD; Soong SJ; Kinney WK; Reid GC; Schray MF; Podratz KC; Morley GW; Shingleton HM
Gynecol Oncol; 1989 Nov; 35(2):130-5. PubMed ID: 2807001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
